April 17th 2025
The CDC advisory committee also endorsed GSK's pentavalent meningococcal vaccine.
FDA Advisers Endorse Natalizumab (Tysabri) for Crohn's Disease
August 2nd 2007GAITHERSBURG, Md. -- FDA advisers have recommended approval of the problem-ridden multiple sclerosis drug natalizumab (Tysabri) for treatment of moderate to severe Crohn's disease, but only with extensive safety monitoring.